Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Der Longevity Report

Zombie cells: how senescence is described and how senolytics are researched

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

At a glance

Automatic summary · not editorially reviewed

The description presents a science documentary on cellular senescence: damaged cells stop dividing, enter a toxic state via p16 and p53 signals, and release a harmful SASP cocktail; senolytic research with quercetin, fisetin and dasatinib is said to target these cells. [1]

  1. The description says damaged cells that never divide again switch into a toxic state called cellular senescence instead of quietly disappearing. [1]

  2. The description attributes the start of cellular standstill to p16 and p53 signalling pathways and says a highly toxic SASP cocktail contaminates healthy neighbouring cells. [1]

  3. The description names senolytics such as quercetin, fisetin and dasatinib and lists five scientific sources, without reporting results, doses or effects in people. [1]

Senescent cells described as toxic and non-dividing

According to the description, the documentary asks what happens in tissue when damaged cells refuse to die. These cells never divide again, but instead of quietly disappearing they switch into a toxic state called cellular senescence. The description attributes the start of this cellular standstill to p16 and p53 signalling pathways. It also says a highly toxic SASP cocktail contaminates healthy neighbouring cells. These are the topics the description says the video covers; the video and transcript were not reviewed. [1]

Senolytics named in the description: quercetin, fisetin, dasatinib

The description says the documentary covers research on senolytics such as quercetin, fisetin and dasatinib, which is described as trying to break through these molecular shields in a targeted way. It lists five scientific sources, including a 2018 Nature Medicine paper by Xu and colleagues titled on improving physical function and increasing lifespan in old age, and a 2020 Journal of Internal Medicine review by Kirkland and Tchkonia on senolytic drugs from discovery to translation. The description does not report results, doses or effects in people; it only names the substances and the cited literature. [1]

Description scope: educational documentary, not medical advice

The description labels the content as a scientific documentary for information, education and awareness based on current biogerontology research. It states explicitly that the content does not replace professional medical advice, diagnosis or treatment. It also invites viewers to subscribe to the channel for documentaries on cell biology, aging research and healthy longevity. The description does not give study design details, sample sizes or follow-up periods for the cited papers, and it does not establish that any listed substance is safe or effective in humans. [1]

Context & limits

Only the video description was available; the video and transcript were not reviewed. The description names substances and cited papers but reports no study design, sample sizes, follow-up, results or human effects, and it states the content is not medical advice.

Based on the creator’s description; the full video and transcript were not analyzed.

[1] Zombie-Zellen: Warum unser Körper altert (Und wie die Wissenschaft sie zerstört)
Quoted passages in the original language
weigern zu sterben? Sie teilen sich nie
p16- und p53-Signalwege eingeleitet wird
Senolytika (wie Quercetin, Fisetin und Dasatinib)

About this video

Creator description · original language

Was geschieht im Gewebe, wenn geschädigte Zellen sich weigern zu sterben? Sie teilen sich nie wieder – doch anstatt lautlos zu vergehen, schalten sie in einen toxischen Zustand: die zelluläre Seneszenz. In dieser wissenschaftlichen Dokumentation beleuchten wir das Phänomen der sogenannten „Zombie-Zellen“. Erfahren Sie, wie zellulärer Stillstand durch p16- und p53-Signalwege eingeleitet wird, warum der hochgiftige SASP-Cocktail gesunde Nachbarzellen kontaminiert und wie die bahnbrechende Forschung an Senolytika (wie Quercetin, Fisetin und Dasatinib) versucht, diese molekularen Schilde gezielt zu durchbrechen. 🔬 Wissenschaftliche Quellen & Studien: 1. Nature Medicine – Xu et al. (2018): „Senolytics improve physical function and increase lifespan in old age.“ 2. Journal of Internal Medicine – Kirkland & Tchkonia (2020): „Senolytic drugs: from discovery to translation.“ 3. Cell – López-Otín et al. (2023): „Hallmarks of aging: An expanding universe (Cellular Senescence).“ 4. Annual Review of Physiology – Campisi, J. (2013): „Aging, Cellular Senescence, and Cancer.“ 5. Aging Cell – Zhu et al. (2015): „The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.“ ⚠️ Medizinischer Hinweis: Dieser Inhalt dient ausschließlich Informations-, Bildungs- und Aufklärungszwecken auf der Grundlage aktueller biogerontologischer Forschung und ersetzt keinesfalls eine professionelle medizinische Beratung, Diagnose oder Behandlung. 🔔 Abonnieren Sie „Der Longevity Report“, um keine fundierten Dokumentationen über Zellbiologie, Alternsforschung und gesunde Langlebigkeit zu verpassen.

Der Longevity Report · 7 min · Source published: 2026-10-04

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…